Literature DB >> 17714026

HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity.

Maximilian Peters1, Natalya M Kogan.   

Abstract

The oxidation of cannabis constituents has given rise to their corresponding quinones, which have been identified as cytotoxic agents. Out of these molecules the quinone of cannabidiol--the most abundant non-psychoactive cannabinoid in Cannabis sativa--has shown the highest cytotoxicity. This compound was named HU-331 and it exerts antiangiogenic properties, induces apoptosis to endothelial cells and inhibits topoisomerase II in nanomolar concentrations. Unlike other quinones, it is not cardiotoxic and does not induce the formation of free radicals. A comparative in vivo study in mice has shown HU-331 to be less toxic and more effective than the commonly used doxorubicin. This review summarises the properties of HU-331 and compares it with doxorubicin and other topoisomerase II inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714026     DOI: 10.1517/13543784.16.9.1405

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  3 in total

Review 1.  An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.

Authors:  Paula Morales; Patricia H Reggio; Nadine Jagerovic
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

2.  The Oxidation of Phytocannabinoids to Cannabinoquinoids.

Authors:  Diego Caprioglio; Daiana Mattoteia; Federica Pollastro; Roberto Negri; Annalisa Lopatriello; Giuseppina Chianese; Alberto Minassi; Juan A Collado; Eduardo Munoz; Orazio Taglialatela-Scafati; Giovanni Appendino
Journal:  J Nat Prod       Date:  2020-04-21       Impact factor: 4.050

Review 3.  Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.

Authors:  István Ujváry; Lumír Hanuš
Journal:  Cannabis Cannabinoid Res       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.